Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai
b'
Causes of chronic liver diseases, emerging treatments, COVID-19
\\nDr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.
\\n\\n--- \\n\\nSend in a voice message: https://podcasters.spotify.com/pod/show/scientificsense/message\\nSupport this podcast: https://podcasters.spotify.com/pod/show/scientificsense/support'